Anticoagulant News and Research

RSS
Decision Resources: Atrial fibrillation drug market to increase more than sevenfold

Decision Resources: Atrial fibrillation drug market to increase more than sevenfold

Latest findings on how blood clots form can open door to the development of new drugs

Latest findings on how blood clots form can open door to the development of new drugs

New guidelines on the management of antithrombotic agents for endoscopic procedures published

New guidelines on the management of antithrombotic agents for endoscopic procedures published

Generic erosion of premium-priced branded agents to offset sales of new agents

Generic erosion of premium-priced branded agents to offset sales of new agents

PolyMedix to present data on its heptagonist compounds

PolyMedix to present data on its heptagonist compounds

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

New oral drug is safe and effective to combat clotting disorder

New oral drug is safe and effective to combat clotting disorder

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Mitral valve repair by experienced surgeons improves the survival rate of patients

Mitral valve repair by experienced surgeons improves the survival rate of patients

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

Overall use of blood-thinning agents not improving despite more options

Overall use of blood-thinning agents not improving despite more options

European Commission and the EMEA approve Angiox in primary PCI for STEMI

European Commission and the EMEA approve Angiox in primary PCI for STEMI

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

Eclipsys reaches milestone: 50 millionth order entered into its EHR system

ARYx Therapeutics announces operating results for the third quarter of 2009

ARYx Therapeutics announces operating results for the third quarter of 2009

Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs

Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs

ThromboGenics issues business update for the third-quarter of 2009

ThromboGenics issues business update for the third-quarter of 2009

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

Recruitment of Phase II trial of TB-402 completed ahead of schedule

Recruitment of Phase II trial of TB-402 completed ahead of schedule

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.